Bioreactors are the potentially used device which is majorly used for biological reactions. These are used to grow numerous organisms such as yeast, bacteria, or animal cell under suitable environments. They maintain a sustainable environment for cell growth and product formation. Bioreactors are majorly used in the pharmaceutical and biotechnology industry for the production of vaccines, antibodies, or biological products. In addition, they are used in industrial processes for cultivating organisms under controlled conditions and for the production of pharmaceutical products for the treatment of various chronic diseases.
According to Data Bridge Market Research the Bioreactors Market accounted for USD 1,327.75 million in 2022, and expected to reach USD 2,439.43 million by 2030. The market is expected to grow with a CAGR of 7.9% in the forecast period of 2023 to 2030.
“Broad applications in the manufacturing of novel molecules”
The increasing adoption of advanced technologies aimed at simplifying complex manufacturing processes is expected to fuel the demand in the market. The segmental statistics are anticipated to be driven by the extensive utilization of bioreactors for the development and production of intricate molecules, including nucleic acids and proteins. These factors play a crucial role in driving the growth of the market.
What restraints the growth of the bioreactors market?
“Stringent rules and regulations”
There are various chemicals used for the manufacturing of bioreactors that are harmful to the environment. Governments globally are addressing this concern by implementing strict laws which the bioreactors industry needs to follow. Governments in several countries have undertaken several measures to deal with waste generation. The laws and regulations prohibit the production of bioreactors which is hindering the market’s growth.
Segmentation: Global Bioreactors Market
The bioreactors market is segmented on the basis of product type, cell, molecule, usage, scale, material, control type, suppliers, and end user
- On the basis of product type, the bioreactors market is segmented into single-use, reusable.
- On the basis of cell, the bioreactors market is segmented into mammalian cells, bacterial cells, and yeast cells.
- On the basis of molecule, the bioreactors market is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy.
- On the basis of usage, the bioreactors market is segmented into lab-scale production, developmental, pre-clinical and clinical, commercial production, pilot-scale production, full-scale production.
- On the basis of scale, the bioreactors market is segmented into 5L-20L, 20L-200L, 200L-1500L, above 1500L.
- On the basis of material, the bioreactors market is segmented into glass, stainless steel, single use.
- On the basis of control type, the bioreactors market is segmented into manual, automated.
- On the basis of suppliers, the bioreactors market is segmented into OEM, system integrators, and EPCs.
- On the basis of end user, the bioreactors market is segmented into research and development departments, research and development institutes, cros, biopharmaceutical companies, biopharmaceutical manufacturer and cmos.
Regional Insights: Asia Pacific dominates the Bioreactors Market
North America dominates the market because of advances in life science research and development Furthermore, an increase in investment and the number of bio-manufacturing facilities will fuel the region's bioreactors market growth during the forecast period.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the rise in chronic diseases Furthermore, the growing demand for novel biologic drugs, as well as the growing number of pharmaceutical companies.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-bioreactors-market
Recent Developments in Bioreactors Market
- In 2022, Merck announced the acquisition of Lonza's MAST platform, an automated aseptic bioreactor sampling system. These platforms assist customers in optimising data during bioprocessing. This acquisition will assist the company in expanding its market presence.
- In 2020, Danaher Corporation acquired General Electric Life Sciences' CYTIVA biopharma business. This strategy has assisted the company in broadening its product offering for biopharma customers and improving market penetration.
The Prominent Key Players Operating in the Bioreactors Market Include:
- Sartorius AG (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- General Electric (U.S.)
- Eppendorf AG (Germany)
- Merck KGaA (Germany)
- Pall Corporation (U.S.)
- ZETA (India)
- PIERRE GUERIN (France)
- PRaj Hipurity Systems Limited (India)
- Bioengineering AG (Switzerland)
- Infors AG (Switzerland)
- Solaris Biotechnology Srl. (Italy)
- Bbi Biotech (Germany)
- Shanghai Bailun Biotechnology co., Ltd. (China)
- PBS Biotech Inc. (U.S.)
- CerCell A/S (Denmark)
- GEA Group Aktiengesellschaft (Germany)
Above are the key players covered in the report, to know about more and exhaustive list of bioreactors market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Bioreactors Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
